Total Payments
$431,707
2024 Payments
$47,825
Companies
19
Transactions
316
Medicare Patients
2,063
Medicare Billing
$199,446
Payment Breakdown by Category
Consulting$230,266 (53.3%)
Other$158,920 (36.8%)
Travel$30,488 (7.1%)
Food & Beverage$11,136 (2.6%)
Gifts$540.00 (0.1%)
Education$355.85 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $230,266 | 34 | 53.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $122,468 | 35 | 28.4% |
| Travel and Lodging | $30,488 | 49 | 7.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $26,500 | 4 | 6.1% |
| Food and Beverage | $11,136 | 182 | 2.6% |
| Honoraria | $9,800 | 3 | 2.3% |
| Gift | $540.00 | 1 | 0.1% |
| Education | $355.85 | 7 | 0.1% |
| Entertainment | $151.86 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Respicardia, Inc. | $140,951 | 10 | $0 (2020) |
| IDORSIA PHARMACEUTICALS US INC | $123,061 | 112 | $0 (2024) |
| ZOLL Respicardia, Inc. | $88,809 | 22 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $31,857 | 70 | $0 (2024) |
| Fisher & Paykel Healthcare Inc | $13,115 | 12 | $0 (2024) |
| Avadel CNS Pharmaceuticals, LLC | $11,038 | 15 | $0 (2024) |
| Philips Electronics North America Corporation | $7,938 | 5 | $0 (2022) |
| Merck Sharp & Dohme LLC | $6,685 | 11 | $0 (2023) |
| HARMONY BIOSCIENCES LLC | $2,616 | 28 | $0 (2024) |
| Eisai Inc. | $1,700 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,825 | 101 | IDORSIA PHARMACEUTICALS US INC ($23,802) |
| 2023 | $115,108 | 108 | IDORSIA PHARMACEUTICALS US INC ($81,255) |
| 2022 | $63,250 | 26 | ZOLL Respicardia, Inc. ($37,259) |
| 2021 | $22,292 | 7 | ZOLL Respicardia, Inc. ($19,000) |
| 2020 | $45,919 | 9 | Respicardia, Inc. ($40,250) |
| 2019 | $62,240 | 24 | Respicardia, Inc. ($42,303) |
| 2018 | $45,177 | 29 | Respicardia, Inc. ($30,990) |
| 2017 | $29,895 | 12 | Respicardia, Inc. ($27,408) |
All Payment Transactions
316 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $5.07 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $28.26 | General |
| Category: Neurology | ||||||
| 12/06/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: NEUROLOGY | ||||||
| 11/26/2024 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: Sleep | ||||||
| 11/18/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,857.50 | General |
| Category: Insomnia | ||||||
| 11/18/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,857.50 | General |
| Category: Insomnia | ||||||
| 11/18/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $60.02 | General |
| Category: Insomnia | ||||||
| 11/18/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $46.90 | General |
| Category: Insomnia | ||||||
| 11/16/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Respiratory | ||||||
| 11/16/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Travel and Lodging | Cash or cash equivalent | $159.00 | General |
| Category: Respiratory | ||||||
| 11/16/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $71.99 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $121.20 | General |
| Category: Insomnia | ||||||
| 11/08/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Narcoplepsy | ||||||
| 11/04/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,492.50 | General |
| Category: Insomnia | ||||||
| 11/04/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $127.30 | General |
| Category: Insomnia | ||||||
| 10/30/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,857.50 | General |
| Category: Insomnia | ||||||
| 10/24/2024 | Itamar Medical Inc | WatchPATONE (Device) | Food and Beverage | Cash or cash equivalent | $36.78 | General |
| Category: Sleep Apnea testing | ||||||
| 10/23/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,492.50 | General |
| Category: Insomnia | ||||||
| 10/23/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $134.00 | General |
| Category: Insomnia | ||||||
| 10/23/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $116.08 | General |
| Category: Insomnia | ||||||
| 10/21/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Travel and Lodging | In-kind items and services | $46.90 | General |
| Category: Insomnia | ||||||
| 10/17/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $124.53 | General |
| Category: Insomnia | ||||||
| 10/15/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $149.86 | General |
| Category: NEUROLOGY | ||||||
| 10/14/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Insomnia | ||||||
| 10/07/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 494 | 554 | $147,330 | $51,154 |
| 2022 | 5 | 486 | 553 | $142,601 | $49,593 |
| 2021 | 7 | 539 | 595 | $143,862 | $52,510 |
| 2020 | 10 | 544 | 593 | $137,304 | $46,189 |
Total Patients
2,063
Total Services
2,295
Medicare Billing
$199,446
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 234 | $54,990 | $20,716 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 102 | 102 | $36,822 | $11,428 | 31.0% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 82 | 83 | $22,576 | $7,427 | 32.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 64 | 65 | $18,330 | $5,851 | 31.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 58 | $9,164 | $3,724 | 40.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 12 | 12 | $5,448 | $2,009 | 36.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 165 | 206 | $48,410 | $19,046 | 39.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 99 | 99 | $35,739 | $10,561 | 29.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 74 | 80 | $22,560 | $7,466 | 33.1% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 82 | 82 | $22,304 | $7,086 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 66 | 86 | $13,588 | $5,433 | 40.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 119 | 136 | $31,960 | $12,424 | 38.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 101 | 101 | $36,461 | $11,783 | 32.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 122 | 149 | $23,542 | $9,466 | 40.2% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2021 | 85 | 87 | $23,664 | $8,206 | 34.7% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2021 | 74 | 80 | $22,560 | $7,904 | 35.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 22 | 23 | $3,680 | $1,627 | 44.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 16 | 19 | $1,995 | $1,100 | 55.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 114 | 127 | $29,845 | $9,546 | 32.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 70 | 70 | $25,270 | $8,227 | 32.6% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Office | 2020 | 74 | 75 | $20,400 | $6,913 | 33.9% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2020 | 71 | 75 | $21,150 | $6,890 | 32.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 115 | 133 | $21,014 | $6,338 | 30.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 38 | 47 | $7,400 | $3,913 | 52.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 22 | 22 | $5,192 | $1,587 | 30.6% |
About Dr. Shahrokh Javaheri, MD
Dr. Shahrokh Javaheri, MD is a Pulmonary Disease healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407829757.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shahrokh Javaheri, MD has received a total of $431,707 in payments from pharmaceutical and medical device companies, with $47,825 received in 2024. These payments were reported across 316 transactions from 19 companies. The most common payment nature is "Consulting Fee" ($230,266).
As a Medicare-enrolled provider, Javaheri has provided services to 2,063 Medicare beneficiaries, totaling 2,295 services with total Medicare billing of $199,446. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Sleep Medicine
- Location Cincinnati, OH
- Active Since 02/08/2006
- Last Updated 01/29/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407829757
Products in Payments
- remede System (Device) $229,760
- QUVIVIQ (Drug) $123,001
- XYREM (Drug) $15,324
- Obstructive Sleep Apnea Device or Hospital Respiratory Equipment (Device) $13,034
- LUMRYZ (Drug) $11,038
- (8362) US Enabling function (Device) $7,818
- Xyrem (Drug) $6,463
- Wakix (Drug) $2,064
- SUNOSI (Drug) $1,579
- WatchPat (Device) $1,500
- XYWAV (Drug) $720.02
- WAKIX (Drug) $552.35
- AirCurve (Device) $540.00
- INSPIRE (Device) $316.38
- Recell (Device) $175.62
- Sunosi (Drug) $169.84
- ApneaLink (Device) $151.86
- Lunoa 1 0 (Device) $74.41
- Tryvio (Drug) $60.41
- FISHER & PAYKEL HEALTHCARE (Device) $52.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Cincinnati
Christopher Radchenko, M.d, M.D
Pulmonary Disease — Payments: $13,708
Pulmonary Disease $13,708
Dr. Karthikeyan Kanagarajan, M.d, M.D
Pulmonary Disease — Payments: $5,575
Pulmonary Disease $5,575
Dr. Christopher Schmitt, M.d, M.D
Pulmonary Disease — Payments: $4,968
Pulmonary Disease $4,968
Dr. Shahla Mallick, Md, MD
Pulmonary Disease — Payments: $4,853
Pulmonary Disease $4,853
Daniel Murphy, Md, MD
Pulmonary Disease — Payments: $3,835
Pulmonary Disease $3,835
Krishna Gannamraj, D.o, D.O
Pulmonary Disease — Payments: $3,039
Pulmonary Disease $3,039